Evidence map›Paper›PMID 42199955›Full record

ArticleKidney international reports2026

The Design and Conduct of Cohort Studies of Peoples With CKD - International Perspectives From iNET-CKD.

Natalia Alencar de Pinho, Laura M Dember, Yosuke Hirakawa, Takahiro Imaizumi, Vivekanand Jha, Adeera Levin, Luxia Zhang, Johannes Benedikt Scheppach, Viviane Calice-Silva, Alejandro Ferreiro-Fuentes and 4 more

Abstract read
In one paragraph

Article in Kidney international reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Natalia Alencar de PinhoClinical Epidemiology and Pharmacoepidemiology Team, CESP (Center for Research in Epidemiology and Population Health), INSERM U1018, Paris-Saclay University, Versailles-Saint Quentin University, Paris, France.
Laura M DemberRenal, Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Yosuke HirakawaDivision of Nephrology and Endocrinology, University of Tokyo School of Medicine, Bunkyo-ku, Tokyo, Japan.
Takahiro ImaizumiDepartment of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
Vivekanand JhaGeorge Institute for Global Health, New Delhi, India.
Adeera LevinDivision of Nephrology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Luxia ZhangRenal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
Johannes Benedikt ScheppachDepartment of Nephrology, Charité Universitätsmedizin Berlin, Berlin, Germany.
Viviane Calice-SilvaResearch Department, Pro-rim Foundation, Joinville, Brazil.
Alejandro Ferreiro-FuentesUnidad Académica de Nefrología. Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.
Manisha SahayNephrology, Osmania Medical College and General Hospital, Hyderabad, Telangana, India.
Maarten TaalCentre for Kidney Research and Innovation, Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK.
Roberto Pecoits-FilhoArbor Research Collaborative for Health, Ann Arbor, Michigan, USA.
International Network of Chronic Kidney Disease Cohort Studies (iNET-CKD) Committee

Funding

Continuation of the Coordinating Center for the Chronic Renal Insufficiency Cohort (CRIC) StudyU24DK060990 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Amanda Hyre Anderson, Laura M Dember · 2018 to 2026
$21.5M
NIDDK NIH HHS U24 DK060990
6 · The paper itself

Abstract

Prospective cohort studies are important for understanding epidemiology, associations, and incidence of adverse outcomes of long-term conditions, including chronic kidney disease (CKD). Here, we draw on the combined expertise of the leaders of cohort studies within the ISN's International Network of CKD Cohorts (iNET-CKD) to provide insights into the design and conduct of prospective cohort studies in people with CKD. Formulating research questions that will remain relevant years after the cohort launch, when data will be available, is the first, and perhaps most challenging step of the study design. These questions will inform participant selection, sample size, duration of follow-up, outcome definitions, as well as frequency of encounters and data collection. Consideration should be given to the data elements to be collected, balancing burden with data value. At least 1 marker of glomerular filtration rate (GFR) (preferably both serum creatinine and cystatin C concentrations) and a measure of proteinuria (preferably urine albumin-to-creatinine ratio) are essential. Standard operating procedures should be developed for all assessments and for biosample collection and storage. Robust governance arrangements should be established to ensure effective management and sustainability of these complex projects, along with sufficient funding for the proposed study duration. Facilitating future collaboration with other cohort studies should be born in mind, to expand scientific output. This includes adoption of standard definitions and assessments, as well as making provisions for sharing of data and biosamples. A clear communication strategy that includes all stakeholders is essential to ensure maximum clinical impact.

Indexed as

biomedical research methodschronic kidney diseasecohort studiesepidemiologyhumansnephrologyresearch and design

Identifiers

PMID42199955
PMCPMC13200014

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.